$BIIB Headlines Goldman's biotech downgrade and the new

New Post Public Reply Private Reply Replies (0) Message Board

Jan 8, 2014 at 2:52 PM

$BIIB Headlines

Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:33 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:19 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:56 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Saumya Vaishampayan
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro
The Four Horsemen send a message 12:47 p.m. Nov. 13, 2013 - The Trading Deck
Biogen shares hit new high as Tecfidera sales crush estimates 9:50 a.m. Oct. 28, 2013 - Russ Britt
Apple is Monday’s stock to watch as results loom 7:22 a.m. Oct. 28, 2013 - Sue Chang
Biogen Idec profit up 22% on Tecfidera sales boost 7:09 a.m. Oct. 28, 2013 - MarketWatch.com
Earnings season focus shifts to revenue, capex 8:53 a.m. Oct. 27, 2013 - Wallace Witkowski
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
Baxter profit falls on costs of Gambro purchase 9:28 a.m. Oct. 17, 2013 - MarketWatch.com
Tesla stuck in reverse, Herbalife loses momentum 3:35 p.m. Oct. 3, 2013 - Sue Chang
Of keg parties and Big Ben 11:29 a.m. Sept. 19, 2013 - The Trading Deck
Charting the technicals ahead of the Fed 10:52 a.m. Sept. 18, 2013 - Michael Ashbaugh

Biogen Idec (BIIB) Highlighted As Momo Momentum Stock 1:50 p.m. Today - TheStreet.com
5 Stocks Improving Performance Of The Health Care Sector 12:03 p.m. Today - TheStreet.com
Nomura starts coverage on multiple biotechs 10:46 a.m. Today - Seeking Alpha
Benzinga's Top Initiations 7:05 a.m. Today - benzinga.com
Notice of Allowance Received by Alkermes - Analyst Blog 4:21 p.m. Jan. 7, 2014 - Zacks.com
Is the Biotech Boom Over? 10:58 a.m. Jan. 7, 2014 - Barrons.com
Jim Cramer's 'Mad Money' Recap: Profiting From Down Days 8:20 p.m. Jan. 6, 2014 - TheStreet.com
Royalty Pharm Acquires Additional Interest in Biogen Drug 9:07 a.m. Jan. 6, 2014 - WSJ.com
Citi's top biotech picks include Biogen, Gilead, and Celgene 8:33 a.m. Jan. 6, 2014 - Seeking Alpha
Perrigo Maintained at Neutral - Analyst Blog 5:35 p.m. Jan. 3, 2014 - Zacks.com
Biogen Leverages Strength In MS Treatments 5:35 p.m. Jan. 3, 2014 - Investors Business Daily
5 Stocks Pulling The Drugs Industry Downward 12:03 p.m. Jan. 3, 2014 - TheStreet.com
Q4 Tecfidera numbers tracking ahead of estimates: Wells Fargo 11:30 a.m. Jan. 3, 2014 - Seeking Alpha
The Top Five Drug Launches Of 2013 12:42 p.m. Dec. 31, 2013 - Investors Business Daily
Health Care Is The Leading Sector In the Big Cap 20 5:04 p.m. Dec. 30, 2013 - Investors Business Daily
Sanofi Appeals MS Drug Rejection 12:20 p.m. Dec. 30, 2013 - WSJ.com
Lemtrada news marginally positive for Biogen: Wells Fargo 9:22 a.m. Dec. 30, 2013 - Seeking Alpha
Bargain-Bin Stocks Take Lead in Rally 5:50 p.m. Dec. 29, 2013 - WSJ.com
Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard 5:01 p.m. Dec. 27, 2013 - TheStreet.com
3 Stocks Dragging In The Drugs Industry 12:03 p.m. Dec. 27, 2013 - TheStreet.com

Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference 5:29 p.m. Jan. 7, 2014 - BusinessWire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
Biogen Idec to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference 4:00 p.m. Jan. 2, 2014 - BusinessWire
Commercialization Agreements, Acquisition Updates, Conference Calls Schedules, Stock Price Updates and Clinical Study Data - Research Report on Biogen Idec, Covidien, Vertex, Endo, and Momenta Pharma 8:00 a.m. Dec. 31, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
WCG Hires Adam Cohen, Digital Thought Leader, to Strengthen Technology Practice 8:00 a.m. Dec. 17, 2013 - BusinessWire
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe 2:00 a.m. Dec. 17, 2013 - BusinessWire
Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America 8:00 a.m. Dec. 13, 2013 - PR Newswire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
Biogen Idec Foundation in Collaboration with Cambridge Community Foundation Awards Grants in Science Education 9:00 a.m. Dec. 11, 2013 - BusinessWire
Swedish Orphan Biovitrum AB (publ): New phase 3 data confirm long-lasting characteristics of rFIXFc and rFVIIIFc across multiple haemophilia populations 11:31 a.m. Dec. 9, 2013 - Thomson Reuters ONE
New Phase 3 Data Confirm Long-Lasting Characteristics Of ALPROLIX(TM) and ELOCTATE(TM) Across Multiple Hemophilia Populations 11:30 a.m. Dec. 9, 2013 - BusinessWire
Proteostasis Therapeutics Announces Collaboration with Biogen Idec for Research, Development and Commercialization of Therapies for Neurodegenerative Diseases 8:30 a.m. Dec. 9, 2013 - BusinessWire
Marketing Rights Acquisitions, PDUFA Date Extensions, Accountable Care Relationship and Stock Price Updates - Research Report on Forest Laboratories, Biogen, Bristol-Myers, Express Scripts, and Aetna 8:00 a.m. Dec. 5, 2013 - PR Newswire
The New England Journal of Medicine publishes pivotal data demonstrating prophylactic infusions of Alprolix(TM) effectively controlled bleeding in haemophilia B patients 2:01 a.m. Dec. 5, 2013 - Thomson Reuters ONE
The New England Journal of Medicine Publishes Pivotal Data Demonstrating Prophylactic Infusions of ALPROLIX(TM) Effectively Controlled Bleeding in Hemophilia B Patients 5:00 p.m. Dec. 4, 2013 - BusinessWire
Sobi's partner Biogen Idec to present phase 3 data on prolonged half-life of Haemophilia candidates in young children at annual ASH meeting 7:31 a.m. Dec. 3, 2013 - Thomson Reuters ONE
Biogen Idec Demonstrates Commitment to Advancing Hemophilia Research and Care at Annual ASH Meeting 7:30 a.m. Dec. 3, 2013 - BusinessWire
Sobi's partner Biogen Idec receives notification from FDA of PDUFA date extension for ALPROLIX(TM) 7:33 a.m. Dec. 2, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

USFCR Wins 2026 Award for Federal Contracting Services

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Veteran Marketer Joins The Wisory's Advisory Board

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Crystal Risotti: Leading IT Compliance in Healthcare

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...